Yes, gonorrhea is curable. A single dose of antibiotics clears most infections, and symptoms typically start improving within a few days. That said, the cure is becoming harder to guarantee as the bacteria rapidly develops resistance to the drugs used against it, making prompt treatment more important than ever.
How Gonorrhea Is Treated
The standard cure for uncomplicated gonorrhea is a single antibiotic injection. Treatment is given in one visit, so there’s no course of pills to remember over several days. Most people notice symptoms like discharge or burning during urination fade within the first week.
After treatment, you need to avoid sexual activity for at least 7 days and until all of your sexual partners have also been treated and any remaining symptoms have resolved. This waiting period isn’t just a precaution. Having sex too soon can spread the infection before the antibiotic has fully done its job, or you can get reinfected immediately from an untreated partner.
If you test positive, your recent sexual partners need treatment too. In many states, a practice called expedited partner therapy allows your doctor to prescribe medication for your partner without requiring them to come in for their own appointment. The CDC considers this a useful option, particularly for male partners of women diagnosed with gonorrhea, since getting partners treated quickly is one of the most effective ways to prevent reinfection.
Why Antibiotic Resistance Is a Growing Concern
Gonorrhea has earned a reputation as one of the most adaptable sexually transmitted infections. The bacteria that causes it, known as the “superbug” in public health circles, has steadily outsmarted nearly every antibiotic thrown at it over the past several decades. Older drug classes have already been abandoned because resistance made them useless. Ciprofloxacin, once a go-to treatment, now fails against 95% of gonorrhea strains worldwide.
The current first-line antibiotic still works for the vast majority of cases, but the trend line is alarming. Between 2022 and 2024, resistance to the two main antibiotics used to treat gonorrhea rose sharply. Resistance to the injectable drug climbed from 0.8% to 5%, and resistance to its oral alternative jumped from 1.7% to 11%. Resistance to azithromycin, previously used as a companion drug, held steady at about 4%. These numbers are still relatively small, but the pace of increase has the World Health Organization warning that treatment options are narrowing.
What this means for you in practical terms: if you’re treated with the standard injection, it will almost certainly work. But if you still have symptoms a week or two after treatment, it’s important to go back for retesting. A resistant strain may require a different antibiotic or a combination approach.
What Happens If Gonorrhea Goes Untreated
Because gonorrhea often causes no symptoms at all, especially in women, it’s possible to carry the infection for weeks or months without knowing. Left untreated, the bacteria can move deeper into the reproductive tract and cause serious damage.
In women, the most significant risk is pelvic inflammatory disease (PID), an infection of the uterus, fallopian tubes, or ovaries. PID can cause chronic pelvic pain and scarring that leads to infertility or increases the risk of ectopic pregnancy, where a fertilized egg implants outside the uterus. In men, untreated gonorrhea can inflame the tube that carries sperm from the testicle, a condition called epididymitis, which can also affect fertility if it goes on long enough.
In rare cases, the bacteria enters the bloodstream and spreads throughout the body. This can cause joint infections, skin lesions, and in the most severe situations, life-threatening inflammation of the heart or brain lining. These complications are uncommon but underscore why screening matters, even if you feel fine.
A New Oral Treatment on the Horizon
One of the limitations of current treatment is that it requires an injection, which means a trip to a clinic. A new antibiotic called zoliflodacin could change that. In a large Phase 3 clinical trial supported by the National Institutes of Health, a single oral dose proved as safe and effective as the standard injection for uncomplicated genital gonorrhea.
Zoliflodacin works through an entirely different mechanism than existing drugs, targeting bacterial DNA replication in a way no current antibiotic does. That novelty is important because the bacteria hasn’t had decades of exposure to build resistance against it. The drug is currently under review by regulatory agencies, and if approved, it would be the first new class of antibiotic for gonorrhea in decades. Having an effective pill instead of a shot could also make treatment more accessible, particularly for people who avoid clinics or live in areas with limited healthcare.
Getting Retested After Treatment
For most people, a single treatment clears the infection completely. However, retesting about three months later is recommended, not because the treatment failed, but because reinfection rates are high. If your partner wasn’t treated or you have a new partner, you can easily catch gonorrhea again.
If you were treated with a non-standard antibiotic, were treated during pregnancy, or have a throat infection (which is harder to clear than genital gonorrhea), a follow-up test sooner after treatment helps confirm the bacteria is actually gone. Throat infections in particular can be stubborn because antibiotic concentrations in throat tissue are lower than in the genital tract.
Gonorrhea doesn’t give you any lasting immunity. You can be cured and reinfected an unlimited number of times, and each new infection carries the same risks of complications if left untreated. Consistent condom use and regular screening if you have new or multiple partners remain the most reliable ways to stay ahead of it.